--- title: "908 Devices Inc. 1Q 2026: Revenue $13.38M, EPS ($0.32) — 10-Q Summary" type: "News" locale: "en" url: "https://longbridge.com/en/news/285371710.md" description: "908 Devices Inc. reported a revenue of $13.38M for Q1 2026, a 13.6% increase from the previous year. However, the net loss widened to $11.96M, or $0.32 per share, compared to a net income of $43.6M, or $1.23 per share, in the prior year. Product revenue grew 26% year-over-year, and gross margin improved to 52%. The company has placed 3,903 handheld units cumulatively, with 167 units in Q1 2026. The transition of the Desktop Portfolio to discontinued operations was completed, contributing to improved margins." datetime: "2026-05-06T11:51:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285371710.md) - [en](https://longbridge.com/en/news/285371710.md) - [zh-HK](https://longbridge.com/zh-HK/news/285371710.md) --- # 908 Devices Inc. 1Q 2026: Revenue $13.38M, EPS ($0.32) — 10-Q Summary 908 Devices Inc. reported first-quarter 2026 results with revenue rising to $13.38M while net loss widened to ($11.96M), or ($0.32) per share, compared with a prior-year net income of $43.6M, or $1.23 per share. **Financial Highlights** Metric Current quarter Prior year quarter YoY change Revenue¹ $13.38M $11.78M 13.6% Net income² ($11.96M) $43.6M (127.4%) Diluted EPS³ ($0.32) $1.23 (126%) _¹ Reported as “Total revenue”. ² Reported as “Net income (loss) attributable to common stockholders”. ³ Reported as “Net income (loss) per share attributable to common stockholders, basic and diluted”._ **Business Highlights** - Product revenue grew 26% year-over-year to $10.7M, driving the increase in total revenue to $13.4M for the quarter. - Shift in channel and mix toward higher-margin domestic federal, state and local device sales and fewer lower-margin international sales helped expand product gross margin to 52%, up about seven percentage points. - Cumulative handheld placements reached 3,903 units, with 167 units placed in 1Q 2026, supporting recurring revenue expansion. - Completed sale of the Desktop Portfolio in Q1 2025 and moved those operations to discontinued operations; transition services largely ended by June 30, 2025. - Lower facility costs following the Boston shutdown contributed to improved margins. Original SEC Filing: 908 Devices Inc. \[ MASS \] - 10-Q - May. 06, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [MASS.US](https://longbridge.com/en/quote/MASS.US.md) - [IBOT.US](https://longbridge.com/en/quote/IBOT.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [ARKQ.US](https://longbridge.com/en/quote/ARKQ.US.md) - [BOTZ.US](https://longbridge.com/en/quote/BOTZ.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [ROBO.US](https://longbridge.com/en/quote/ROBO.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) ## Related News & Research - [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md) - [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md) - [This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday](https://longbridge.com/en/news/294224687.md) - [China sweeps global humanoid robot start-up ranking as US imposes ban](https://longbridge.com/en/news/294162239.md) - [Has the bull market shifted to biotech stocks?](https://longbridge.com/en/news/293077044.md)